Eva Bredberg

1.3k total citations
20 papers, 1.1k citations indexed

About

Eva Bredberg is a scholar working on Pharmacology, Oncology and Surgery. According to data from OpenAlex, Eva Bredberg has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Eva Bredberg's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Eva Bredberg is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Eva Bredberg collaborates with scholars based in Sweden, United Kingdom and United States. Eva Bredberg's co-authors include Mohammed Hassan‐Alin, Kerstin Röhss, Tommy B. Andersson, Ulf Diczfalusy, Leif Bertilsson, Tommy Andersson, Kajsa P. Kanebratt, Ylva Böttiger, Tobias Bäckström and L Paalzow and has published in prestigious journals such as Gastroenterology, Journal of Pharmacology and Experimental Therapeutics and Pharmaceutical Research.

In The Last Decade

Eva Bredberg

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Bredberg Sweden 17 444 321 313 174 115 20 1.1k
Shin Irie Japan 24 375 0.8× 207 0.6× 441 1.4× 610 3.5× 289 2.5× 89 1.9k
Barbara Schug Germany 16 110 0.2× 105 0.3× 112 0.4× 73 0.4× 151 1.3× 47 991
A.N. Chremos United States 18 333 0.8× 115 0.4× 108 0.3× 64 0.4× 126 1.1× 26 821
Hee Youn Choi South Korea 15 568 1.3× 110 0.3× 45 0.1× 174 1.0× 103 0.9× 40 1.0k
Darcy J. Mulford United States 18 596 1.3× 420 1.3× 132 0.4× 70 0.4× 118 1.0× 40 1.2k
H.‐U. Schulz Germany 15 235 0.5× 68 0.2× 239 0.8× 154 0.9× 141 1.2× 49 912
Géraldine M. Ferron United States 19 168 0.4× 71 0.2× 278 0.9× 231 1.3× 303 2.6× 28 1.1k
Akinori Urae Japan 17 215 0.5× 136 0.4× 494 1.6× 503 2.9× 185 1.6× 30 1.2k
Walter Krauwinkel Netherlands 23 184 0.4× 52 0.2× 161 0.5× 226 1.3× 201 1.7× 52 1.3k
Bimal Malhotra United States 20 134 0.3× 68 0.2× 191 0.6× 198 1.1× 162 1.4× 69 1.5k

Countries citing papers authored by Eva Bredberg

Since Specialization
Citations

This map shows the geographic impact of Eva Bredberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Bredberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Bredberg more than expected).

Fields of papers citing papers by Eva Bredberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Bredberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Bredberg. The network helps show where Eva Bredberg may publish in the future.

Co-authorship network of co-authors of Eva Bredberg

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Bredberg. A scholar is included among the top collaborators of Eva Bredberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Bredberg. Eva Bredberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Björkhem‐Bergman, Linda, Tobias Bäckström, Hanna Nylén, et al.. (2014). Quinine Compared to 4β-Hydroxycholesterol and Midazolam as Markers for CYP3A Induction by Rifampicin. Drug Metabolism and Pharmacokinetics. 29(4). 352–355. 18 indexed citations
2.
Björkhem‐Bergman, Linda, Tobias Bäckström, Hanna Nylén, et al.. (2013). Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin. Drug Metabolism and Disposition. 41(8). 1488–1493. 65 indexed citations
3.
Diczfalusy, Ulf, Kajsa P. Kanebratt, Eva Bredberg, et al.. (2008). 4β‐Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half‐life of elimination after induction with rifampicin. British Journal of Clinical Pharmacology. 67(1). 38–43. 107 indexed citations
4.
Kanebratt, Kajsa P., Ulf Diczfalusy, Tobias Bäckström, et al.. (2008). Cytochrome P450 Induction by Rifampicin in Healthy Subjects: Determination Using the Karolinska Cocktail and the Endogenous CYP3A4 Marker 4β-Hydroxycholesterol. Clinical Pharmacology & Therapeutics. 84(5). 589–594. 116 indexed citations
5.
Andersson, Tommy B., et al.. (2004). AN EVALUATION OF THE IN VITRO METABOLISM DATA FOR PREDICTING THE CLEARANCE AND DRUG-DRUG INTERACTION POTENTIAL OF CYP2C9 SUBSTRATES. Drug Metabolism and Disposition. 32(7). 715–721. 56 indexed citations
6.
Andersson, Tommy, et al.. (2004). RESPONSE: PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES. Drug Metabolism and Disposition. 32(12). 1523–1523. 3 indexed citations
7.
Bredberg, Eva, Tommy B. Andersson, Lars Frison, et al.. (2003). Ximelagatran, an Oral Direct Thrombin Inhibitor, Has a Low Potential for Cytochrome P450-Mediated Drug-Drug Interactions. Clinical Pharmacokinetics. 42(8). 765–777. 83 indexed citations
8.
Hallerbäck, B., Gilles Bommelaer, Eva Bredberg, et al.. (2002). Dose finding study of mosapride in functional dyspepsia: a placebo‐controlled, randomized study. Alimentary Pharmacology & Therapeutics. 16(5). 959–967. 91 indexed citations
9.
Andersson, Tommy, Kerstin Röhss, Eva Bredberg, & Mohammed Hassan‐Alin. (2001). Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole. Alimentary Pharmacology & Therapeutics. 15(10). 1563–1569. 136 indexed citations
10.
Hassan‐Alin, Mohammed, et al.. (2000). Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. European Journal of Clinical Pharmacology. 56(9-10). 665–670. 126 indexed citations
11.
Andersson, Tommy, Eva Bredberg, Maria Sunzel, Madeleine Antonsson, & Lars Weidolf. (2000). Pharmacokinetics (PK) and effect on pentagastrin stimulated peak acid output (PAO) of omeprazole (O) and its 2 optical isomers, S-omeprazole/esomeprazole (E) and R-omeprazole (R-O). Gastroenterology. 118(4). A1210–A1210. 21 indexed citations
12.
Andersson, Tommy, Kerstin Röhss, Mohammed Hassan‐Alin, & Eva Bredberg. (2000). Pharmacokinetics (PK) and dose-response relationship of esomeprazole (E). Gastroenterology. 118(4). A1210–A1210. 16 indexed citations
13.
Bredberg, Eva, et al.. (1998). Lack of drug-drug interaction between three different non-steroidal anti-inflammatory drugs and omeprazole. European Journal of Clinical Pharmacology. 54(5). 399–404. 25 indexed citations
14.
Halldin, Magnus M., Eva Bredberg, B. Angelin, et al.. (1996). Metabolism and excretion of ropivacaine in humans.. Drug Metabolism and Disposition. 24(9). 962–968. 48 indexed citations
15.
Bredberg, Eva, et al.. (1994). Pharmacokinetics of Levodopa and Carbidopa in Rats Following Different Routes of Administration. Pharmaceutical Research. 11(4). 549–555. 31 indexed citations
16.
Bredberg, Eva, et al.. (1993). Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease. European Journal of Clinical Pharmacology. 45(2). 117–122. 54 indexed citations
17.
Tedroff, Joakim, Sten‐Magnus Aquilonius, Per Hartvig, et al.. (1992). Cerebral uptake and utilization of therapeutic [β-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor response. Acta Neurologica Scandinavica. 85(2). 95–102. 36 indexed citations
18.
Bredberg, Eva & L Paalzow. (1991). Effects of apomorphine on heart rate during simultaneous administration of sulpiride: a challenge of the composed concentration-effect model.. Journal of Pharmacology and Experimental Therapeutics. 258(3). 1055–1060. 3 indexed citations
19.
Bredberg, Eva, Joakim Tedroff, S.‐M. Aquilonius, & L Paalzow. (1990). Pharmacokinetics and effects of levodopa in advanced Parkinson's disease. European Journal of Clinical Pharmacology. 39(4). 385–389. 37 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin Irie Breakdown of academic impact, for papers by Barbara Schug Breakdown of academic impact, for papers by A.N. Chremos Breakdown of academic impact, for papers by Hee Youn Choi Breakdown of academic impact, for papers by Darcy J. Mulford Breakdown of academic impact, for papers by H.‐U. Schulz Breakdown of academic impact, for papers by Géraldine M. Ferron Breakdown of academic impact, for papers by Akinori Urae Breakdown of academic impact, for papers by Walter Krauwinkel Breakdown of academic impact, for papers by Bimal Malhotra
Rankless by CCL
2026